Stroke patients, what to do and what to avoid

Area of Science:

• Neurology
• Emergency Medicine
• Cardiovascular Research

Background:

• Ischemic stroke is a significant cause of mortality and morbidity in Italy, with 130,000 new cases annually and a 6.5% prevalence.
• Effective management of acute ischemic stroke requires a multidisciplinary approach involving prompt physician evaluation and intervention.

Purpose of the Study:

• To outline the essential components of emergent evaluation and treatment for acute ischemic stroke.
• To emphasize the critical time window for thrombolytic therapy in ischemic stroke management.

Main Methods:

• Initial assessment focusing on airway, breathing, cardiocirculatory status, and neurological examination within 5-10 minutes.
• Prioritization of a plain CT scan of the brain for diagnosis, especially to rule out intracranial hemorrhage.
• Emergency management strategies including correction of hypovolemia, hypoxia, and treatment of severe hypertension, hypoglycemia, intracranial hypertension, and seizures.

Main Results:

• The primary goal of emergency therapy is to maintain adequate cerebral perfusion by managing intracranial pressure and mean arterial pressure.
• Intravenous thrombolytic therapy with recombinant tissue plasminogen activator (r-TPA) is recommended within 3 hours of ischemic stroke onset when no contraindications exist.
• Evidence supporting the efficacy of intravenous r-TPA beyond 3 hours from stroke onset is lacking.

Conclusions:

• Rapid and accurate assessment is vital for acute ischemic stroke patients.
• Timely administration of intravenous r-TPA within the established 3-hour window is critical for potential patient benefit.
• Further research may be needed to explore treatment options for ischemic stroke beyond the 3-hour time frame.